1. Home
  2. MXL vs SANA Comparison

MXL vs SANA Comparison

Compare MXL & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MaxLinear Inc.

MXL

MaxLinear Inc.

HOLD

Current Price

$19.19

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Sana Biotechnology Inc.

SANA

Sana Biotechnology Inc.

HOLD

Current Price

$4.72

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MXL
SANA
Founded
2003
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
MXL
SANA
Price
$19.19
$4.72
Analyst Decision
Buy
Strong Buy
Analyst Count
7
7
Target Price
$20.25
$7.83
AVG Volume (30 Days)
972.8K
3.2M
Earning Date
01-29-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$423,372,000.00
N/A
Revenue This Year
$30.54
N/A
Revenue Next Year
$18.23
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.53
N/A
52 Week Low
$8.35
$1.26
52 Week High
$25.73
$6.55

Technical Indicators

Market Signals
Indicator
MXL
SANA
Relative Strength Index (RSI) 59.03 57.10
Support Level $17.90 $4.37
Resistance Level $19.12 $4.92
Average True Range (ATR) 0.77 0.29
MACD -0.03 0.04
Stochastic Oscillator 75.06 83.84

Price Performance

Historical Comparison
MXL
SANA

About MXL MaxLinear Inc.

MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Share on Social Networks: